{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T20:40:50Z","timestamp":1789332050982,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LZ24H160004"],"award-info":[{"award-number":["LZ24H160004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001459","name":"Government of Singapore Ministry of Education","doi-asserted-by":"publisher","award":["NUHSRO\/2021\/061\/T1\/Seed-Mar\/04"],"award-info":[{"award-number":["NUHSRO\/2021\/061\/T1\/Seed-Mar\/04"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["226-2025-00101"],"award-info":[{"award-number":["226-2025-00101"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["K20220228"],"award-info":[{"award-number":["K20220228"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92353303"],"award-info":[{"award-number":["92353303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22325704"],"award-info":[{"award-number":["22325704"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270746"],"award-info":[{"award-number":["32270746"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271331"],"award-info":[{"award-number":["32271331"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203415"],"award-info":[{"award-number":["82203415"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jare.2026.08.055","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:36:56Z","timestamp":1788190616000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Driver genomic lesions in MDM2, CDK4, and JUN co-opt targetable super-enhancer networks to impose liposarcomagenic core regulatory circuitry"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0357-1434","authenticated-orcid":false,"given":"Ye","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan Zea","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8176-3509","authenticated-orcid":false,"given":"Pushkar","family":"Dakle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suya","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7957-540X","authenticated-orcid":false,"given":"Chenying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Kwanmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingwen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7842-7034","authenticated-orcid":false,"given":"Qiaoyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4257-3355","authenticated-orcid":false,"given":"Wen","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Phillip","family":"Koeffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2700-4840","authenticated-orcid":false,"given":"Liang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2026.08.055_b0005","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41568-020-0288-4","article-title":"The epigenomics of sarcoma","volume":"20","author":"Nacev","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jare.2026.08.055_b0010","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.1038\/s41388-020-01459-w","article-title":"Core transcriptional regulatory circuitries in cancer","volume":"39","author":"Chen","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2026.08.055_b0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","article-title":"Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial","volume":"15","author":"Judson","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jare.2026.08.055_b0020","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0140-6736(15)01283-0","article-title":"Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial","volume":"387","author":"Schoffski","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jare.2026.08.055_b0025","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"379","author":"van der Graaf","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jare.2026.08.055_b0030","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1158\/1078-0432.CCR-19-1824","article-title":"Correlative analyses of the SARC028 trial reveal an association between sarcoma-associated immune infiltrate and response to pembrolizumab","volume":"26","author":"Keung","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2026.08.055_b0035","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s43018-024-00726-z","article-title":"A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity\/truncal undifferentiated pleomorphic sarcoma","volume":"5","author":"Roland","year":"2024","journal-title":"Nat Cancer"},{"key":"10.1016\/j.jare.2026.08.055_b0040","unstructured":"e.d.s.c. Cancer Genome Atlas Research Network. Electronic address, N. Cancer Genome Atlas Research, Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas, Cell, 171 (2017) 950-965 e928."},{"key":"10.1016\/j.jare.2026.08.055_b0045","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1038\/s41467-019-13286-z","article-title":"Integrated exome and RNA sequencing of dedifferentiated liposarcoma","volume":"10","author":"Hirata","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2026.08.055_b0050","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1158\/1078-0432.CCR-19-0271","article-title":"Genomic evolutionary patterns of leiomyosarcoma and liposarcoma","volume":"25","author":"Amin-Mansour","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2026.08.055_b0055","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s42003-024-06307-1","article-title":"MDM2 amplification in rod-shaped chromosomes provides clues to early stages of circularized gene amplification in liposarcoma","volume":"7","author":"Sydow","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.jare.2026.08.055_b0060","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S1470-2045(12)70474-6","article-title":"Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study","volume":"13","author":"Ray-Coquard","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jare.2026.08.055_b0065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejca.2017.02.005","article-title":"A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours","volume":"76","author":"de Jonge","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jare.2026.08.055_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103636","article-title":"A first-in-human phase I study of a novel MDM2\/p53 inhibitor alrizomadlin in advanced solid tumors","volume":"9","author":"Zhang","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.jare.2026.08.055_b0075","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.22.01285","article-title":"A first-in-human phase I study of milademetan, an MDM2 inhibitor, patients with advanced liposarcoma, solid tumors, or lymphomas","volume":"41","author":"Gounder","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2026.08.055_b0080","article-title":"Impact of supraphysiologic MDM2 expression on chromatin networks and therapeutic responses in sarcoma","volume":"3","author":"Bevill","year":"2023","journal-title":"Cell Genom"},{"key":"10.1016\/j.jare.2026.08.055_b0085","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.molcel.2016.04.033","article-title":"Chromatin-bound MDM2 regulates serine metabolism and redox homeostasis independently of p53","volume":"62","author":"Riscal","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.jare.2026.08.055_b0090","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2163","article-title":"Targeting MDM2-dependent serine metabolism as a therapeutic strategy for liposarcoma","volume":"12","author":"Cisse","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jare.2026.08.055_b0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molcel.2015.12.008","article-title":"MDM2 associates with polycomb repressor complex 2 and enhances stemness-promoting chromatin modifications independent of p53","volume":"61","author":"Wienken","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.jare.2026.08.055_b0100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102420118","article-title":"MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53","volume":"118","author":"Klein","year":"2021","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2026.08.055_b0105","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1631\/jzus.B2500021","article-title":"Exploiting targeted degradation of cyclins and cyclin-dependent kinases for cancer therapeutics: a review","volume":"26","author":"Zheng","year":"2025","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.jare.2026.08.055_b0110","article-title":"Clinical utility of CDK4\/6 inhibitors in sarcoma: successes and future challenges","volume":"6","author":"Hsu","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jare.2026.08.055_b0115","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/1078-0432.CCR-21-1291","article-title":"Co-targeting of MDM2 and CDK4\/6 with siremadlin and ribociclib for the treatment of patients with well-differentiated or dedifferentiated liposarcoma: results from a proof-of-concept, phase ib study","volume":"28","author":"Abdul Razak","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2026.08.055_b0120","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s41374-019-0263-4","article-title":"Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology","volume":"99","author":"Kim","year":"2019","journal-title":"Lab Invest"},{"key":"10.1016\/j.jare.2026.08.055_b0125","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/s41467-019-09257-z","article-title":"Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma","volume":"10","author":"Chen","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2026.08.055_b0130","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41305","article-title":"Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma","volume":"7","author":"Brien","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.jare.2026.08.055_b0135","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1038\/s41467-019-11046-7","article-title":"Chemical genomics reveals histone deacetylases are required for core regulatory transcription","volume":"10","author":"Gryder","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2026.08.055_b0140","doi-asserted-by":"crossref","first-page":"11434","DOI":"10.1093\/nar\/gkaa901","article-title":"EWS-FLI1 regulates and cooperates with core regulatory circuitry in Ewing sarcoma","volume":"48","author":"Shi","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jare.2026.08.055_b0145","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/s41388-026-03794-w","article-title":"XPO1 inhibitor KPT-330 disrupts the core transcriptional regulatory circuitry of dedifferentiated liposarcoma by modulating the translation process","volume":"45","author":"Fan","year":"2026","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2026.08.055_b0150","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/path.2564","article-title":"c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme","volume":"218","author":"Snyder","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.jare.2026.08.055_b0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2007.10.032","article-title":"Characterization of the 12q amplicons by high-resolution, oligonucleotide array CGH and expression analyses of a novel liposarcoma cell line","volume":"260","author":"Persson","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jare.2026.08.055_b0160","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/gcc.2870050403","article-title":"Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11)","volume":"5","author":"Aman","year":"1992","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jare.2026.08.055_b0165","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<30::AID-IJC6>3.0.CO;2-4","article-title":"Identification of genes differentially expressed in TLS-CHOP carrying myxoid liposarcomas","volume":"83","author":"Thelin-Jarnum","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jare.2026.08.055_b0170","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/1097-0215(20001215)88:6<889::AID-IJC8>3.0.CO;2-N","article-title":"LiSa-2, a novel human liposarcoma cell line with a high capacity for terminal adipose differentiation","volume":"88","author":"Wabitsch","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jare.2026.08.055_b0175","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41388-021-01661-4","article-title":"MNK1 and MNK2 enforce expression of E2F1, FOXM1, and WEE1 to drive soft tissue sarcoma","volume":"40","author":"Ke","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2026.08.055_b0180","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ng.619","article-title":"Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy","volume":"42","author":"Barretina","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jare.2026.08.055_b0185","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2026.08.055_b0190","doi-asserted-by":"crossref","first-page":"E5086","DOI":"10.1073\/pnas.1712363115","article-title":"Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma","volume":"115","author":"Xu","year":"2018","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2026.08.055_b0195","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1158\/0008-5472.CAN-18-2918","article-title":"MDM2-recruiting PROTAC offers superior, synergistic antiproliferative activity via simultaneous degradation of BRD4 and stabilization of p53","volume":"79","author":"Hines","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2026.08.055_b0200","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1038\/sj.onc.1205541","article-title":"Mdm2 inhibition of p53 induces E2F1 transactivation via p21","volume":"21","author":"Wunderlich","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2026.08.055_b0205","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1038\/sj.onc.1208814","article-title":"Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway","volume":"24","author":"Zhang","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2026.08.055_b0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/gcc.20012","article-title":"ASK1 (MAP3K5) as a potential therapeutic target in malignant fibrous histiocytomas with 12q14-q15 and 6q23 amplifications","volume":"40","author":"Chibon","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jare.2026.08.055_b0215","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/modpathol.2015.96","article-title":"Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas","volume":"28","author":"Saada-Bouzid","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jare.2026.08.055_b0220","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ccr.2007.02.007","article-title":"JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas","volume":"11","author":"Mariani","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jare.2026.08.055_b0225","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1172\/JCI77976","article-title":"Increased H3K9me3 drives dedifferentiated phenotype via KLF6 repression in liposarcoma","volume":"125","author":"Keung","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2026.08.055_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100494","article-title":"GLI1 coamplification in well-differentiated\/dedifferentiated liposarcomas: clinicopathologic and molecular analysis of 92 cases","volume":"37","author":"Sharma","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jare.2026.08.055_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114005","article-title":"A recurrent NTRK1 tyrosine kinase domain mutation pair is characteristic in a subset of dedifferentiated liposarcomas","volume":"202","author":"Lippai","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jare.2026.08.055_b0240","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1038\/s41388-023-02768-6","article-title":"Notch signaling regulates a metabolic switch through inhibiting PGC-1alpha and mitochondrial biogenesis in dedifferentiated liposarcoma","volume":"42","author":"Tien","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2026.08.055_b0245","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1021\/acs.jmedchem.8b00909","article-title":"Discovery of MD-224 as a first-in-class, highly potent, and efficacious proteolysis targeting chimera murine double minute 2 degrader capable of achieving complete and durable Tumor regression","volume":"62","author":"Li","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.jare.2026.08.055_b0250","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1158\/0008-5472.CAN-22-3173","article-title":"Proteasome inhibition sensitizes liposarcoma to MDM2 inhibition with nutlin-3 by activating the ATF4\/CHOP stress response pathway","volume":"83","author":"Ludwig","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2026.08.055_b0255","article-title":"Harnessing MDM2-mediated targeted degradation of transcriptional and epigenetic machinery to disrupt oncogenic addictions in pediatric sarcoma","volume":"13","author":"Zhou","year":"2026","journal-title":"Adv Sci (Weinh)"},{"issue":"2026","key":"10.1016\/j.jare.2026.08.055_b0260","article-title":"Discovery of a first-in-class murine double minute 2-recruiting positive transcription elongation factor B PROTAC degrader with selective antitumor activity","volume":"7","author":"Guan","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.jare.2026.08.055_b0265","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-026-09134-w","article-title":"Targeted degradation of P-TEFb via MDM2 substrate substitution collapses oncogenic transcriptional programs in MDM2-amplified cancers","author":"Chen","year":"2026","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jare.2026.08.055_b0270","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1158\/1535-7163.MCT-14-0387","article-title":"Antiproliferative effects of CDK4\/6 inhibition in CDK4-amplified human liposarcoma in vitro and in vivo","volume":"13","author":"Zhang","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jare.2026.08.055_b0275","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40164-024-00540-4","article-title":"Role of CDK4 as prognostic biomarker in Soft Tissue Sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatment","volume":"13","author":"Vanni","year":"2024","journal-title":"Exp Hematol Oncol"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226006879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226006879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:53:56Z","timestamp":1788494036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123226006879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":55,"alternative-id":["S2090123226006879"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2026.08.055","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Driver genomic lesions in MDM2, CDK4, and JUN co-opt targetable super-enhancer networks to impose liposarcomagenic core regulatory circuitry","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2026.08.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}